The role of stem cells in developing new drugs
30 Oct 2012Cambridge team which developed method to generate liver cells from skin cells has formed a new company to supply stem cell products to the drug discovery and regenerative medicine sectors.
News from Cambridge Enterprise.
Cambridge team which developed method to generate liver cells from skin cells has formed a new company to supply stem cell products to the drug discovery and regenerative medicine sectors.
A series of programmes which aim to address and counteract radical thought in British youth is now being adapted for use across Europe.
By using thorium instead of uranium as fuel, nuclear power could be safer and more sustainable, according to new research.
Technology developed at the University of Cambridge to detect peripheral visual field loss in young children will enable the earlier detection of brain tumours, potentially saving sight and lives.
Consultancy is an effective way for academics to share their knowledge and expertise, bridging the gap between research and industry.
A new method for identifying which bones have a high risk of fracture, and for monitoring the effectiveness of new bone-strengthening drugs and techniques, has been developed by scientists at the University of Cambridge.
Knowledge transfer (KT) is a term used to encompass a very broad range of activities to support mutually beneficial collaborations between universities, businesses and the public sector.
An innovative new project spearheaded by Cambridge Enterprise Ltd and researchers in the Department of Chemistry is taking a proactive approach to intellectual property (IP) and commercialisation.